NIDAN — Nidan Laboratories and Healthcare Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Market Cap
IN₹189.04m
Enterprise Value
IN₹280.73m
Revenue
IN₹255.42m

Annual income statement for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	297	243	242	245	255
Cost of Revenue
Gross Profit	266	232	232	238	245
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	92.8	61.3	150	54.8	76
Operating Profit	204	181	91.8	190	179
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	45.2	48.1	-23.7	27.6	24.4
Provision for Income Taxes
Net Income After Taxes	26.6	35.4	-32.3	19.8	15.1
Net Income Before Extraordinary Items
Net Income	26.6	35.4	-32.3	19.8	15.1
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	26.6	35.4	-32.3	19.8	15.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.17	2.4	0.722	1.41	1.26